These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

264 related items for PubMed ID: 10675213

  • 1. Atrophy of the corpus callosum associated with a decrease in cortical benzodiazepine receptor in large cerebral arterial occlusive diseases.
    Yamauchi H, Fukuyama H, Dong Y, Nabatame H, Nagahama Y, Nishizawa S, Konishi J, Shio H.
    J Neurol Neurosurg Psychiatry; 2000 Mar; 68(3):317-22. PubMed ID: 10675213
    [Abstract] [Full Text] [Related]

  • 2. Atrophy of the corpus callosum associated with cognitive impairment and widespread cortical hypometabolism in carotid artery occlusive disease.
    Yamauchi H, Fukuyama H, Nagahama Y, Katsumi Y, Dong Y, Konishi J, Kimura J.
    Arch Neurol; 1996 Nov; 53(11):1103-9. PubMed ID: 8912483
    [Abstract] [Full Text] [Related]

  • 3. Progression of atrophy of the corpus callosum with deterioration of cerebral cortical oxygen metabolism after carotid artery occlusion: a follow up study with MRI and PET.
    Yamauchi H, Pagani M, Fukuyama H, Ouchi Y, Nagahama Y, Matsuzaki S, Kimura J, Yonekura Y, Konishi J.
    J Neurol Neurosurg Psychiatry; 1995 Oct; 59(4):420-6. PubMed ID: 7561923
    [Abstract] [Full Text] [Related]

  • 4. Callosal atrophy with reduced cortical oxygen metabolism in carotid artery disease.
    Yamauchi H, Fukuyama H, Nabatame H, Harada K, Kimura J.
    Stroke; 1993 Jan; 24(1):88-93. PubMed ID: 8418557
    [Abstract] [Full Text] [Related]

  • 5. Selective neuronal damage and borderzone infarction in carotid artery occlusive disease: a 11C-flumazenil PET study.
    Yamauchi H, Kudoh T, Kishibe Y, Iwasaki J, Kagawa S.
    J Nucl Med; 2005 Dec; 46(12):1973-9. PubMed ID: 16330559
    [Abstract] [Full Text] [Related]

  • 6. Assessment of benzodiazepine receptors using iodine-123-labeled iomazenil single-photon emission computed tomography in patients with ischemic cerebrovascular disease. A comparison with PET study.
    Dong Y, Fukuyama H, Nabatame H, Yamauchi H, Shibasaki H, Yonekura Y.
    Stroke; 1997 Sep; 28(9):1776-82. PubMed ID: 9303025
    [Abstract] [Full Text] [Related]

  • 7. Atrophy of the corpus callosum, cortical hypometabolism, and cognitive impairment in corticobasal degeneration.
    Yamauchi H, Fukuyama H, Nagahama Y, Katsumi Y, Dong Y, Hayashi T, Konishi J, Kimura J.
    Arch Neurol; 1998 May; 55(5):609-14. PubMed ID: 9605717
    [Abstract] [Full Text] [Related]

  • 8. Selective neuronal damage and chronic hemodynamic cerebral ischemia.
    Yamauchi H, Kudoh T, Kishibe Y, Iwasaki J, Kagawa S.
    Ann Neurol; 2007 May; 61(5):454-65. PubMed ID: 17380523
    [Abstract] [Full Text] [Related]

  • 9. Comparison of the pattern of atrophy of the corpus callosum in frontotemporal dementia, progressive supranuclear palsy, and Alzheimer's disease.
    Yamauchi H, Fukuyama H, Nagahama Y, Katsumi Y, Hayashi T, Oyanagi C, Konishi J, Shio H.
    J Neurol Neurosurg Psychiatry; 2000 Nov; 69(5):623-9. PubMed ID: 11032614
    [Abstract] [Full Text] [Related]

  • 10. Corpus callosum atrophy in amyotrophic lateral sclerosis.
    Yamauchi H, Fukuyama H, Ouchi Y, Nagahama Y, Kimura J, Asato R, Konishi J.
    J Neurol Sci; 1995 Dec; 134(1-2):189-96. PubMed ID: 8747865
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Selective neuronal damage and Wisconsin Card Sorting Test performance in atherosclerotic occlusive disease of the major cerebral artery.
    Yamauchi H, Nishii R, Higashi T, Kagawa S, Fukuyama H.
    J Neurol Neurosurg Psychiatry; 2011 Feb; 82(2):150-6. PubMed ID: 20802218
    [Abstract] [Full Text] [Related]

  • 13. Central benzodiazepine receptor binding potential and CBF images on SPECT correlate with oxygen extraction fraction images on PET in the cerebral cortex with unilateral major cerebral artery occlusive disease.
    Chida K, Ogasawara K, Kuroda H, Aso K, Kobayashi M, Fujiwara S, Yoshida K, Terasaki K, Ogawa A.
    J Nucl Med; 2011 Apr; 52(4):511-8. PubMed ID: 21421729
    [Abstract] [Full Text] [Related]

  • 14. Atrophy of the corpus callosum, cognitive impairment, and cortical hypometabolism in progressive supranuclear palsy.
    Yamauchi H, Fukuyama H, Nagahama Y, Katsumi Y, Dong Y, Konishi J, Kimura J.
    Ann Neurol; 1997 May; 41(5):606-14. PubMed ID: 9153522
    [Abstract] [Full Text] [Related]

  • 15. In vivo imaging of region and cell type specific neocortical neurodegeneration in Alzheimer's disease. Perspectives of MRI derived corpus callosum measurement for mapping disease progression and effects of therapy. Evidence from studies with MRI, EEG and PET.
    Hampel H, Teipel SJ, Alexander GE, Pogarell O, Rapoport SI, Möller HJ.
    J Neural Transm (Vienna); 2002 May; 109(5-6):837-55. PubMed ID: 12111472
    [Abstract] [Full Text] [Related]

  • 16. Assessment of outcome by EC/IC bypass with 123I-iomazenil brain SPECT.
    Makino K, Kamiyama H, Takamura H, Gotoh S, Kobayashi N.
    Ann Nucl Med; 1999 Aug; 13(4):261-4. PubMed ID: 10510883
    [Abstract] [Full Text] [Related]

  • 17. Callosal atrophy parallels decreased cortical oxygen metabolism and neuropsychological impairment in Alzheimer's disease.
    Yamauchi H, Fukuyama H, Harada K, Nabatame H, Ogawa M, Ouchi Y, Kimura J, Konishi J.
    Arch Neurol; 1993 Oct; 50(10):1070-4. PubMed ID: 8215966
    [Abstract] [Full Text] [Related]

  • 18. Corpus callosum atrophy is a possible indicator of region- and cell type-specific neuronal degeneration in Alzheimer disease: a magnetic resonance imaging analysis.
    Hampel H, Teipel SJ, Alexander GE, Horwitz B, Teichberg D, Schapiro MB, Rapoport SI.
    Arch Neurol; 1998 Feb; 55(2):193-8. PubMed ID: 9482361
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. [123I]Iomazenil SPECT benzodiazepine receptor imaging in schizophrenia.
    Verhoeff NP, Soares JC, D'Souza CD, Gil R, Degen K, Abi-Dargham A, Zoghbi SS, Fujita M, Rajeevan N, Seibyl JP, Krystal JH, van Dyck CH, Charney DS, Innis RB.
    Psychiatry Res; 1999 Oct 11; 91(3):163-73. PubMed ID: 10641580
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.